Heart Failure (HF) is escalating, resulting in thousands of deaths annually among people in Canada. Despite the availability of diagnostic and management tools for heart failure, significant obstacles hinder the provision of effective, patient-oriented care.
Building on our 2022 Patient & Caregiver Charter, The Heartlife Foundation developed the Framework to give decision makers the tools to improve patient outcomes and reduce costs on our healthcare system.
▪ Second most expensive health condition in Canada, costing $575.2 million in hospital costs in 2016-2017.
▪ $2.8 billion per year in expected associated HF costs by 2030 associated with heart failure in Canada.
▪ Simple interventions, like better testing implementation, could save $268-$347 million annually based on projected healthcare resource reductions
Provide and reimburse natriuretic peptide testing for all patients on first presentation to any healthcare setting with symptoms suggestive of new or worsening heart failure.
Patients with heart failure should be on all 4 guideline-directed medications (GDMT), at a maximally tolerated dose for them, within 3 to 6 months from their initial diagnosis.
It is essential for provincial and federal political and administrative leadership to actively work to implement the framework recommendations, and everyday People in Canada can help. The HeartLife Foundation is advocating for change in Canada, urging participation in advocacy initiatives and donations to support People in Canada with heart failure. By actively participating in initiatives and supporting the foundation, individuals can contribute to substantial improvements in heart failure care and outcomes.